Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synvisc in Insertional Achilles Tendinopathy
NCT02368561Phase 1Unknown
- Sponsor
- Meir Medical Center
- Start
- Mar 2015
- Primary completion
- Jan 2016
01
Overview
Phase 1, open-label, single-arm trial of sodium hyaluronate in Achilles tendinopathy, sponsored by Meir Medical Center. Primary endpoint: Victorian Institute of Sports Assessment-Achilles at 6 months. Status: unknown.
02
Drugs
sodium hyaluronate
03
Conditions
Achilles tendinopathy
Beyond the preview
Go deeper on NCT02368561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368561.